Prosztatarák: vizsgálatok itt: Svájc
43 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in SvájcErectile Function PRESERVation in Definitive Radiotherapy for Prostate Cancer by MRI-Enhanced Adaptive Sparing of the Neurovascular Bundle
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 48
- Run by
- University of Zurich
See details and how to joinNCT07916779 - No phaseTaking peopleAccurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
- Where
- Lausanne
- Életkor
- 18 év and over
- People
- 74
- Run by
- University of Lausanne Hospitals
See details and how to joinNCT06482489 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Aarau, Basel, Fribourg, Geneva, Zurich
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - No phaseTaking peoplePULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
- Where
- Basel
- People
- 753
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07484269 - 2. fázisTaking peopleTerbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
- Where
- Baden, Basel, Bellinzona, Chur, Frauenfeld, Geneva, Lucerne, Rapperswil, Sankt Gallen, Winterthur, Zurich
- Életkor
- 18 év and over
- People
- 42
- Run by
- Swiss Cancer Institute
See details and how to joinNCT07365423 - 3. fázisTaking peopleTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Where
- Aarau
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT05946213 - 3. fázisTaking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Geneva, Lucerne, Zurich
- Életkor
- 18 év to 100 év
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - 3. fázisTaking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Bern, Lausanne, Sankt Gallen, Zurich
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - 3. fázisTaking peopleAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Bern, Geneva, Zurich
- Életkor
- 18 év and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - 3. fázisTaking peopleSaruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Where
- Aarau, Chur
- Életkor
- 18 év and over
- People
- 1330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00 - 3. fázisTaking peopleThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Where
- Bern
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00 - 2. fázisTaking peopleDarolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Where
- Aarau, Baden, Bellinzona, Bern, Chur, Geneva, Lausanne, Lucerne, Sankt Gallen, Winterthur, Zurich
- Életkor
- 18 év and over
- People
- 162
- Run by
- Swiss Cancer Institute
See details and how to joinNCT06401980 - 3. fázisTaking peopleStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Where
- Aarau
- Életkor
- 18 év and over
- People
- 1273 worldwide
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT03678025 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Chur, Sankt Gallen, Winterthur
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - No phaseTaking peopleTractography-Guided Nerve-Sparing in Prostate Cancer
- Where
- Geneva
- Életkor
- 18 év and over
- People
- 23
- Run by
- Massimo Valerio
See details and how to joinNCT07847385 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Basel, Bellinzona, Sankt Gallen
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 2/3. fázisTaking peopleOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Where
- Basel, Bellinzona, Bern
- Életkor
- 18 év to 100 év
- People
- 443 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00 - No phaseTaking peopleSPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer
- Where
- Geneva
- Életkor
- 18 év and over
- People
- 26
- Run by
- Massimo Valerio
See details and how to joinNCT07826858 - 1/2. fázisTaking peopleInvestigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
- Where
- Bellinzona
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Institute of Cancer Research, United Kingdom
See details and how to joinNCT07002320 - 3. fázisNot yet taking people in SvájcBest Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
- Where
- Aarau, Bellinzona, Bern, Chur, Münsterlingen, Winterthur, Zurich
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Ente Ospedaliero Cantonale, Bellinzona
See details and how to joinNCT07782112 - 1. fázisTaking peopleStudy of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Bellinzona, Chur, Lausanne, Sankt Gallen
- Életkor
- 18 év and over
- People
- 479 worldwide
- Run by
- Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00 - No phaseNot yet taking people in SvájcWeekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- University of Zurich
See details and how to joinNCT07591051 - No phaseTaking peopleEvaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)
- Where
- Basel
- Életkor
- 50 év and over
- People
- 300
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07762911 - 1/2. fázisNot yet taking people in SvájcFAPI PET Imaging - An Exploratory Study
- Where
- Baden, Geneva, Genolier, Lucerne, Zurich
- Életkor
- 18 év and over
- People
- 770
- Run by
- Martin Huellner
See details and how to joinNCT07705074